Kartogenin and Its Application in Regenerative Medicine

Abstract

Regenerative medicine refers to the possibility of replacing aged/damaged cells with genetically similar young and functional cells to restore or establish normal function. Kartogenin (KGN), a small heterocyclic, drug-like compound was discovered in 2012, which is strongly associated with regenerative medicine. KGN has been applied in many regenerative fields, including cartilage regeneration and protection, tendon-bone healing, wound healing, and limb development. KGN could facilitate cartilage repair, promote formation of cartilage-like transition zone in tendon-bone junctions, stimulate collagen synthesis for wound healing, and regulate limb development in a coordinated manner. Considering the related mechanism, filamin A/CBFβ/RUNX1, Ihh, and TGFβ/Smad pathways have been reported to involve KGN. Therefore, KGN is proven a promising agent in regenerative medicine; however, studies conducted on the effect of KGN are limited to date and not convictive for long-term use. Further studies are recommended to explore the long-term effect and potential molecular mechanisms of KGN. Our investigations may motivate researchers to expand its applications in different forms and fields.

Keywords

kartogenin / regenerative medicine / mechanism

References

[1] KahnA. Regenerative medicine. J Soc Biol, 2001, 195(1): 5-7

[2] MasonC, DunnillP. A brief definition of regenerative medicine. Regen Med, 2008, 3(1): 1-5

[3] TerzicA, NelsonTJ. Regenerative medicine advancing health care 2020. J Am Coll Cardiol, 2010, 55(20): 2254-2257

[4] HayekA, Kerstetter-FogleAE, SachlosE, et al.. Kartogenin: a game-changer in regenerative medicine. Regen Med, 2012, 7(4): 475

[5] JohnsonK, ZhuS, TremblayMS, et al.. A stem cell-based approach to cartilage repair. Science, 2012, 336(6082): 717-721

[6] MariniJC, ForlinoA. Replenishing cartilage from endogenous stem cells. N Engl J Med, 2012, 366(26): 2522-2524

[7] KangML, KoJY, KimJE, et al.. Intra-articular delivery of kartogenin-conjugated chitosan nano/microparticles for cartilage regeneration. Biomaterials, 2014, 35(37): 9984-9994

[8] DeckerRS, KoyamaE, Enomoto-IwamotoM, et al.. Mouse limb skeletal growth and synovial joint development are coordinately enhanced by Kartogenin. Dev Biol, 2014, 395(2): 255-267

[9] MohanG, MagnitskyS, MelkusG, et al.. Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis: A pilot study. J Orthop Res, 2016, 34(10): 1780-1789

[10] LiuC, LiT, YangZ, et al.. Kartogenin Enhanced Chondrogenesis in Cocultures of Chondrocytes and Bone Mesenchymal Stem Cells. Tissue Eng Part A, 2018, 24(11–12): 990-1000

[11] ShiD, XuX, YeY, et al.. Photo-Cross-Linked Scaffold with Kartogenin-Encapsulated Nanoparticles for Cartilage Regeneration. ACS Nano, 2016, 10(1): 1292-1299

[12] LuHH, ThomopoulosS. Functional attachment of soft tissues to bone: development, healing, and tissue engineering. Annu Rev Biomed Eng, 2013, 15: 201-226

[13] GalatzLM, SandellLJ, RothermichSY, et al.. Characteristics of the rat supraspinatus tendon during tendon-to-bone healing after acute injury. J Orthop Res, 2006, 24(3): 541-550

[14] RothrauffBB, TuanRS. Cellular therapy in bone-tendon interface regeneration. Organogenesis, 2014, 10(1): 13-28

[15] ZhangJ, WangJH. Kartogenin induces cartilage-like tissue formation in tendon-bone junction. Bone Res, 2014, 2(ii): 14008

[16] ZhouY, ZhangJ, YangJ, et al.. Kartogenin with PRP promotes the formation of fibrocartilage zone in the tendon-bone interface. J Tissue Eng Regen Med, 2017, 11(12): 3445-3456

[17] WangD, TanH, LebaschiAH, et al.. Kartogenin Enhances Collagen Organization and Mechanical Strength of the Repaired Enthesis in a Murine Model of Rotator Cuff Repair. Arthroscopy, 2018, 34(9): 2579-2587

[18] MartinP. Wound healing-aiming for perfect skin regeneration. Science, 1997, 276(5309): 75-81

[19] GibranNS, BoyceS, GreenhalghDG. Cutaneous wound healing. J Burn Care Res, 2007, 28(4): 577-579

[20] SingerAJ, ClarkRA. Cutaneous wound healing. N Engl J Med, 1999, 341(10): 738-746

[21] RuszczakZ. Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev, 2003, 55(12): 1595-1611

[22] WangJ, ZhouJ, ZhangN, et al.. A heterocyclic molecule kartogenin induces collagen synthesis of human dermal fibroblasts by activating the smad4/smad5 pathway. BiochemBiophys Res Commun, 2014, 450(1): 568-574

[23] StormEE, KingsleyDM. GDF5 coordinates bone and joint formation during digit development. Dev Biol, 1999, 209(1): 11-27

[24] KhanIM, RedmanSN, WilliamsR, et al.. The development of synovial joints. Curr Top Dev Biol, 2007, 79: 1-36

[25] HolderN. An experimental investigation into the early development of the chick elbow joint. J Embryol Exp Morphol, 1977, 39: 115-127

[26] ItoMM, KidaMY. Morphological and biochemical reevaluation of the process of cavitation in the rat knee joint: cellular and cell strata alterations in the interzone. J Anat, 2000, 197(Pt4): 659-679

[27] YoshidaN, OgataT, TanabeK, et al.. Filamin A-bound PEBP2beta/CBFbeta is retained in the cytoplasm and prevented from functioning as a partner of the Runx1 transcription factor. Mol Cell Biol, 2005, 25(3): 1003-1012

[28] KamekuraS, KawasakiY, HoshiK, et al.. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum, 2006, 54(8): 2462-2470

[29] ZhengQ, ZhouG, MorelloR, et al.. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol, 2003, 162(5): 833-842

[30] WeiJ, ShimazuJ, MakinistogluMP, et al.. Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. Cell, 2015, 161(7): 1576-1591

[31] MininaE, WenzelHM, KreschelC, et al.. BMP and Ihh/ PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development, 2001, 128(22): 4523-4534

[32] KronenbergHM. Developmental regulation of the growth plate. Nature, 2003, 423(6937): 332-336

[33] TukachinskyH, LopezLV, SalicA. A mechanism for vertebrate Hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes. J Cell Biol, 2010, 191(2): 415-428

[34] YangJ, AndreP, YeL, et al.. The Hedgehog signalling pathway in bone formation. Int J Oral Sci, 2015, 7(2): 73-79

[35] Blaney DavidsonEN, VittersEL, van den BergWB, et al.. TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7. Arthritis Res Ther, 2006, 8(3): R65

[36] DenisJF, SaderF, GatienS, et al.. Activation of Smad2 but not Smad3 is required to mediate TGF-beta signaling during axolotl limb regeneration. Development, 2016, 143(19): 3481-3490

[37] ChongAK, SatterwhiteT, PhamHM, et al.. Live imaging of Smad2/3 signaling in mouse skin wound healing. Wound Repair Regen, 2007, 15(5): 762-766

[38] LoiselleAE, YukataK, GearyMB, et al.. Development of antisense oligonucleotide (ASO) technology against Tgf-beta signaling to prevent scarring during flexor tendon repair. J Orthop Res, 2015, 33(6): 859-866

[39] MatsumotoY, OtsukaF, HinoJ, et al.. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling. Mol Cell Endocrinol, 2012, 350(1): 78-86

[40] NishidaT, KubotaS, AoyamaE, et al.. Impaired glycolytic metabolism causes chondrocyte hypertrophylike changes via promotion of phospho-Smad1/5/8 translocation into nucleus. Osteoarthritis Cartilage, 2013, 21(5): 700-709

[41] van CaamA, Blaney DavidsonE, MadejW, et al.. Pronounced decrease in expreßsion of chondroprotective Smad2/3 phosphorylating TGFβ-signaling receptors during ageing in healthy cartilage. Osteoarthritis Cartilage, 2013, 21(Suppl): S130